These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 31188743)
1. Red blood cells participate in reverse cholesterol transport by mediating cholesterol efflux of high-density lipoprotein and apolipoprotein A-I from THP-1 macrophages. Lai SJ; Ohkawa R; Horiuchi Y; Kubota T; Tozuka M Biol Chem; 2019 Nov; 400(12):1593-1602. PubMed ID: 31188743 [TBL] [Abstract][Full Text] [Related]
2. Coffee consumption enhances high-density lipoprotein-mediated cholesterol efflux in macrophages. Uto-Kondo H; Ayaori M; Ogura M; Nakaya K; Ito M; Suzuki A; Takiguchi S; Yakushiji E; Terao Y; Ozasa H; Hisada T; Sasaki M; Ohsuzu F; Ikewaki K Circ Res; 2010 Mar; 106(4):779-87. PubMed ID: 20075335 [TBL] [Abstract][Full Text] [Related]
3. Enhanced atheroprotection and lesion remodelling by targeting the foam cell and increasing plasma cholesterol acceptors. Son SH; Goo YH; Choi M; Saha PK; Oka K; Chan LC; Paul A Cardiovasc Res; 2016 Feb; 109(2):294-304. PubMed ID: 26487692 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the cholesterol efflux of apolipoprotein E-containing high-density lipoprotein in THP-1 cells. Horiuchi Y; Ohkawa R; Lai SJ; Yamazaki A; Ikoma H; Yano K; Kameda T; Tozuka M Biol Chem; 2019 Jan; 400(2):209-218. PubMed ID: 30210053 [TBL] [Abstract][Full Text] [Related]
9. Niacin decreases removal of high-density lipoprotein apolipoprotein A-I but not cholesterol ester by Hep G2 cells. Implication for reverse cholesterol transport. Jin FY; Kamanna VS; Kashyap ML Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2020-8. PubMed ID: 9351367 [TBL] [Abstract][Full Text] [Related]
10. Cell surface-expressed moesin-like HDL/apoA-I binding protein promotes cholesterol efflux from human macrophages. Matsuyama A; Sakai N; Hiraoka H; Hirano K; Yamashita S J Lipid Res; 2006 Jan; 47(1):78-86. PubMed ID: 16251720 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein A-I-stimulated apolipoprotein E secretion from human macrophages is independent of cholesterol efflux. Kockx M; Rye KA; Gaus K; Quinn CM; Wright J; Sloane T; Sviridov D; Fu Y; Sullivan D; Burnett JR; Rust S; Assmann G; Anantharamaiah GM; Palgunachari MN; Katz SL; Phillips MC; Dean RT; Jessup W; Kritharides L J Biol Chem; 2004 Jun; 279(25):25966-77. PubMed ID: 15066991 [TBL] [Abstract][Full Text] [Related]
12. HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity. Borja MS; Ng KF; Irwin A; Hong J; Wu X; Isquith D; Zhao XQ; Prazen B; Gildengorin V; Oda MN; Vaisar T J Lipid Res; 2015 Oct; 56(10):2002-9. PubMed ID: 26254308 [TBL] [Abstract][Full Text] [Related]
13. Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation. Moore RE; Navab M; Millar JS; Zimetti F; Hama S; Rothblat GH; Rader DJ Circ Res; 2005 Oct; 97(8):763-71. PubMed ID: 16151025 [TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases-3, -7, and -12, but not -9, reduce high density lipoprotein-induced cholesterol efflux from human macrophage foam cells by truncation of the carboxyl terminus of apolipoprotein A-I. Parallel losses of pre-beta particles and the high affinity component of efflux. Lindstedt L; Saarinen J; Kalkkinen N; Welgus H; Kovanen PT J Biol Chem; 1999 Aug; 274(32):22627-34. PubMed ID: 10428843 [TBL] [Abstract][Full Text] [Related]
15. Localization of an apolipoprotein A-I epitope critical for lipoprotein-mediated cholesterol efflux from monocytic cells. Banka CL; Black AS; Curtiss LK J Biol Chem; 1994 Apr; 269(14):10288-97. PubMed ID: 7511599 [TBL] [Abstract][Full Text] [Related]
16. Cholesterol efflux to high-density lipoproteins and apolipoprotein A-I phosphatidylcholine complexes is inhibited by ethanol: role of apolipoprotein structure and cooperative interaction of phosphatidylcholine and cholesterol. Avdulov NA; Chochina SV; Igbavboa U; Wood WG Biochemistry; 2000 Aug; 39(34):10599-606. PubMed ID: 10956052 [TBL] [Abstract][Full Text] [Related]
17. Reduction of paraoxonase-1 activity may contribute the qualitative impairment of HDL particles in patients with type 2 diabetes. Murakami H; Tanabe J; Tamasawa N; Matsumura K; Yamashita M; Matsuki K; Murakami H; Matsui J; Suda T Diabetes Res Clin Pract; 2013 Jan; 99(1):30-8. PubMed ID: 23137417 [TBL] [Abstract][Full Text] [Related]